Pfizer Inc , which in May abandoned its $118 billion bid to buy AstraZeneca Plc , on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals. Under UK takeover rules, AstraZeneca can attempt to re-engage with Pfizer in August, and Pfizer can make another run at AstraZeneca in November. Pfizer officially gave up its six-month quest to buy AstraZeneca after its final bid was rejected. Pfizer shares have been flat this year, against an 11 percent gain for the drug sector, due to declining revenue.
via Health News Headlines - Yahoo News http://ift.tt/1uDYm9c
No comments:
Post a Comment